Market Overview

Trade SMED stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
2/03/20Stifel NicolausUpgradesHoldBuy6.0
7/24/19Roth CapitalInitiates Coverage OnBuy4.5
4/30/18Stifel NicolausDowngradesBuyHold
Show more Loading articles...

Earnings View Earnings

Q2 2020 EST Actual Surprise
EPS: 0.030 0.060 0.0300
Rev: 12.11M 14.57M 2.46M
Q3 2020 EST Actual Surprise
EPS: Expected
2020-04-22
Rev:

Company Profile